Company: BLTE
Filing Date: 2025-10-22
Form Type: F-3ASR
Source: 0001104659-25-101403
Chunk: 64

Company: BELITE BIO, INC
Filing Date: 2025-10-22
Form: F-3ASR
Chunk 64
---
 thereby) or interests in ordinary shares (or ADSs represented thereby) received after the date of this prospectus from a selling securityholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their ordinary shares (or ADSs represented thereby) or interests in ordinary shares (or ADSs represented thereby) on any stock exchange, market or trading facility on which the ordinary shares (or ADSs represented thereby) are traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.

The Selling Shareholders may use any one or more of the following methods when disposing of ordinary shares (or ADSs represented thereby) or interests therein:

•

distributions to members, partners, stockholders or other equityholders of the Selling Shareholders;

•

ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

•

block trades in which the broker-dealer will attempt to sell the ordinary shares (or ADSs represented thereby) as agent, but may position and resell a portion of the block as principal to facilitate the transaction;

•

purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

•

an exchange distribution in accordance with the rules of the applicable exchange;

•

privately negotiated transactions;

•

short sales and settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;

•

through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

•

broker-dealers may agree with the Selling Shareholders to sell a specified number of such shares at a stipulated price per ordinary shares (or ADSs represented thereby);

•

a combination of any such methods of sale; and

•

any other method permitted pursuant to applicable law.

The Selling Shareholders may, from time to time, pledge or grant a security interest in some or all of the ordinary shares (or ADSs represented thereby) owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the ordinary shares (or ADSs represented thereby), from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act, amending the